| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate |
2012-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24f7a030a85bc9d774d5da1ae90694f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff52b6fe1f8eb7b6f0fba093575d233e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbed60a30fb16396fa399e8bd6b4bdb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_127ab914ffcbff5fa8a8deb101b819e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7308589a625e5d99d0b2164e3c4f3809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cd231a47b4ff7b7634446d8db94a4fe |
| publicationDate |
2020-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2856607-C |
| titleOfInvention |
Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide |
| abstract |
The present invention relates to polymorphs and hydrates of 2-(2-methylamino- pyrimidin-4-yl)-1H-indole-5-carboxylic acid [(S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl- amino)-ethyl]-amide, processes for their preparation and their use, in particular in pharmaceutical compositions. |
| priorityDate |
2011-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |